Home » Topics » Substance use and poisoning, BioWorld Science

Substance use and poisoning, BioWorld Science
RSS

NIH renews research funding for Homspera in radiation-induced lung injury

Aug. 27, 2010

Aoxing receives approval in China for buprenorphine/naloxone clinical trial

Aug. 26, 2010

Bolder BioTech receives grant to study IL-11 analogue for acute radiation syndrome

Aug. 23, 2010

NIDA awards grant to Selecta Biosciences for nicotine vaccine development

Aug. 17, 2010

Humanetics receives licenses for medical radiation countermeasures

Aug. 16, 2010

Nabilone shows promise to treat cannabis use disorders

Aug. 10, 2010

Patient enrollment advances ahead of schedule in phase III Probuphine trial

Aug. 4, 2010

FDA grants CBLB-502 fast track status for acute radiation syndrome

July 23, 2010

Cangene's option to license Maxygen's MAXY-G34 for ARS expires

July 19, 2010

Nabi completes enrollment in first of two phase III NicVAX trials

July 15, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...